MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspring

Brain

Volumn 121, Issue 10, 1998, Pages 1889-1894

  Chinnery, Patrick F ^a   Howell, Neil ^b   Lightowlers, Robert N ^a   Turnbull, Douglass M ^a,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Maternal inheritance; MELAS; MERRF; Mitochondrial encephalomyopathies; Mitochondrial inheritance

Indexed keywords

MITOCHONDRIAL DNA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CLINICAL ARTICLE; ENCEPHALOMYOPATHY; FEMALE; GENE MUTATION; GENETIC COUNSELING; HUMAN; INHERITANCE; LACTIC ACIDOSIS; MELAS SYNDROME; MERRF SYNDROME; MOTHER; MYOCLONUS EPILEPSY; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; PROGENY; RISK ASSESSMENT;

ADOLESCENT; ADULT; FEMALE; GENETICS, POPULATION; HUMANS; INCIDENCE; MATERNAL-FETAL EXCHANGE; MELAS SYNDROME; MERRF SYNDROME; MIDDLE AGED; POINT MUTATION; PREGNANCY;

EID: 0031712755     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/121.10.1889     Document Type: Article

References (52)

1. Altman D. Practical statistics for medical research. London: Chapman and Hall; 1991.
2. Attardi G, Yoneda M, Chomyn A. Complementation and segregation behavior of disease causing mitochondrial DNA mutations in cellular model systems. [Review]. Biochim Biophys Acta 1995; 1271:241-8.
3. Campos Y, Bautista J, Gutierrez-Rivas E, Chinchon D, Cabello A, Segura D, et al. Clinical heterogeneity in two pedigrees with the 3243 bp tRNA(Leu(UUR)) mutation of mitochondrial DNA. Acta Neurol Scand 1995; 91: 62-5.
4. Chinnery PF, Turnbull DM. The clinical features, investigation and management of patients with defects of mitochondrial DNA [editorial]. [Review]. J Neurol Neurosurg Psychiatry 1997a; 63: 559-63.
5. Chinnery PF, Turnbull DM. Mitochondrial medicine. QJM 1997b; 90: 657-67.
6. Chinnery PF, Howell N, Lightowlers RN, Turnbull DM. Molecular pathology of MELAS and MERRF: the relationship between mutation load and clinical phenotypes. Brain 1997; 120: 1713-21.
7. Chomyn A, Meola G, Bresolin N, Lai ST, Scarlato G, Attardi G. In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria. Mol Cell Biol 1991; 11: 2236-44.
8. Chu NS, Huang CC, Wei YH. Genetic analysis of one family with myoclonic epilepsy and ragged-red fibers (MERFF) [letter]. Muscle Nerve 1994; 17: 1230.
9. Ciafaloni E, Ricci E, Shanske S, Moraes CT, Silvestri G, Hirano M, et al. MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol 1992; 31: 391-8.
10. Daly LE, Bourke GJ, McGilvray J. Interpretation and uses of medical statistics. 4th ed. Oxford: Blackwell Scientific; 1991.
11. Degoul F, Diry M, Pou-Serradell A, Lloreta J, Marsac C. Myoleukoencephalopathy in twins: study of 3243-myopathy, encephalopathy, lactic acidosis, and strokelike episodes mitochondrial DNA mutation. Ann Neurol 1994; 35: 365-70.
12. de Vries D, de Wijs I, Ruitenbeek W, Begeer J, Smit P, Bentlage H, et al. Extreme variability of clinical symptoms among sibs in a MELAS family correlated with heteroplasmy for the mitochondrial A3243G mutation. J Neurol Sci 1994; 124: 77-82.
13. Dougherty FE, Ernst SG, Aprille JR. Familial recurrence of atypical symptoms in an extended pedigree with the syndrome of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). J Pediatr 1994; 125: 758-61.
14. Enriquez JA, Chomyn A, Attardi G. MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNA(Lys) and premature translation termination. Nat Genet 1995; 10: 47-55.
15. Graf WD, Sumi SM, Copass MK, Ojemann LM, Longstreth WT Jr, Shanske S, et al. Phenotypic heterogeneity in families with the myoclonic epilepsy and ragged-red fiber disease point mutation in mitochondrial DNA. Ann Neurol 1993; 33: 640-5.
16. Hammans SR, Sweeney MG, Brockington M, Lennox GG, Lawton NF, Kennedy CR, et al. The mitochondrial DNA transfer RNA(Lys)A→G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA. Brain 1993; 116: 617-32.
17. Hammans SR, Sweeney MG, Hanna MG, Brockington M, Morgan-Hughes JA, Harding AE. The mitochondrial DNA transfer RNALeu(UUR) A→G(3243) mutation. A clinical and genetic study. Brain 1995; 118: 721-34.
18. Harding AE, Sweeney MG, Govan GG, Riordan-Eva P. Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. Am J Hum Genet 1995; 57: 77-86.
19. Holme E, Tulinius MH, Larsson NG, Oldfors A. Inheritance and expression of mitochondrial DNA point mutations. Biochim Biophys Acta 1995; 1271: 249-52.
20. Huang CC, Chen RS, Chen CM, Wang HS, Lee CC, Pang CY, et al. MELAS syndrome with mitochondrial tRNA(Leu(UUR)) gene mutation in a Chinese family. J Neurol Neurosurg Psychiatry 1994; 57: 586-9.
21. Huang CC, Chen RS, Chu NS, Pang CY, Wei YH. Random mitotic segregation of mitochondrial DNA in MELAS syndrome. Acta Neurol Scand 1996; 93: 198-202.
22. Kaufmann P, Koga Y, Shanske S, Hirano M, DiMauro S, King MP, et al. Mitochondrial DNA and RNA processing in MELAS. Ann Neurol 1996; 40: 172-80.
23. Kishimoto M, Hashiramoto M, Araki S, Ishida Y, Kazumi T, Kanda E, et al. Diabetes mellitus carrying a mutation in the mitochondrial tRNA(Leu(UUR)) gene. Diabetologia 1995; 38: 193-200.
24. Kobayashi Y, Ichihashi K, Ohta S, Nihei K, Kagawa Y, Yanagisawa M, et al. The mutant mitochondrial genes in mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) were selectively amplified through generations. J Inherit Metab Dis 1992; 15: 803-8.
25. Larsson NG, Clayton DA. Molecular genetic aspects of human mitochondrial disorders. [Review]. Annu Rev Genet 1995; 29: 151-78.
26. Larsson NG, Tulinius MH, Holme E, Oldfors A, Andersen O, Wahlstrom J, et al. Segregation and manifestations of the mtDNA tRNA(Lys) A→G(8344) mutation of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am J Hum Genet 1992; 51: 1201-12.
27. Lightowlers RN, Chinnery PF, Turnbull DM, Howell N. Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet 1997; 13: 450-55.
28. Liou CW, Huang CC, Chee EC, long YJ, Tsai JL, Pang CY, et al. MELAS syndrome: correlation between clinical features and molecular genetic analysis. Acta Neurol Scand 1994; 90: 354-9.
29. Macmillan C, Kirkham T, Fu K, Allison V, Andermann E, Babul A, et al. Pedigree analysis of Leber's hereditary optic neuropathy families with the T14484C MtDNA mutation [abstract]. Neurology 1997; 48 (3 Suppl 2): A245-6.
30. Mariotti C, Savarese N, Suomalainen A, Rimoldi M, Comi G, Prelle A, et al. Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA. J Neurol 1995; 242: 304-12.
31. Martinuzzi A, Bartolomei L, Carrozzo R, Mostacciuolo M, Carbonin C, Toso V, et al. Correlation between clinical and molecular features in two MELAS families. J Neurol Sci 1992; 113: 222-9.
32. Matthews PM, Hopkin J, Brown RM, Stephenson JB, Hilton-Jones D, Brown GK. Comparison of the relative levels of the 3243 (A→G) mtDNA mutation in heteroplasmic adult and fetal tissues. J Med Genet 1994; 31: 41-4.
33. Moraes CT, Ciacci F, Silvestri G, Shanske S, Sciacco M, Hirano M, et al. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul Disord 1993; 3: 43-50.
34. Mosewich RK, Donat JR, DiMauro S, Ciafaloni E, Shanske S, Erasmus M, et al. The syndrome of mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes presenting without stroke. Arch Neurol 1993; 50: 275-8.
35. Ozawa M, Goto Y, Sakuta R, Tanno Y, Tsuji S, Nonaka I. The 8,344 mutation in mitochondrial DNA: a comparison between the proportion of mutant DNA and clinico-pathologic findings. Neuromuscul Disord 1995; 5: 483-8.
36. Piccolo G, Focher F, Verri A, Spadari S, Banfi P, Gerosa E, et al. Myoclonus epilepsy and ragged-red fibers: blood mitochondrial DNA heteroplasmy in affected and asymptomatic members of a family. Acta Neurol Scand 1993; 88: 406-9.
37. Reardon W, Ross RJ, Sweeney MG, Luxon LM, Pembrey ME, Harding AE et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA [see comments]. Lancet 1992; 340: 1376-9. Comment in: Lancet 1993; 341: 437-9, Comment in: Lancet 1993; 341-341: 1291-2.
38. Reardon W, Ross RJ, Sweeney MG, Luxon LM, Pembrey ME, Harding AE et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA [see comments]. Lancet 1992; 340: 1376-9. Comment in: Lancet 1993; 341: 437-9, Comment in: Lancet 1993; 341-341: 1291-2.
39. Reardon W, Ross RJ, Sweeney MG, Luxon LM, Pembrey ME, Harding AE et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA [see comments]. Lancet 1992; 340: 1376-9. Comment in: Lancet 1993; 341: 437-9, Comment in: Lancet 1993; 341-341: 1291-2.
40. Remes AM, Majamaa K, Herva R, Hassinen IE. Adult-onset diabetes mellitus and neurosensory hearing loss in maternal relatives of MELAS patients in a family with tRNALeu(UUR) mutation. Neurology 1993; 43: 1015-20.
41. Rusanen H, Majamaa K, Tolonen U, Remes AM, Myllyla R, Hassinen IE. Demyelinating polyneuropathy in a patient with the tRNA(Leu(UUR)) mutation at base pair 3243 of the mitochondrial DNA [see comments]. Neurology 1995; 45: 1188-92. Comment in: Neurology 1996; 46: 1494-6.
42. Rusanen H, Majamaa K, Tolonen U, Remes AM, Myllyla R, Hassinen IE. Demyelinating polyneuropathy in a patient with the tRNA(Leu(UUR)) mutation at base pair 3243 of the mitochondrial DNA [see comments]. Neurology 1995; 45: 1188-92. Comment in: Neurology 1996; 46: 1494-6.
43. Schon EA, Bonilla E, DiMauro S. Mitochondrial DNA mutations and pathogenesis. [Review]. J Bioenerg Biomembr 1997; 29: 131-49.
44. Seibel P, Degoul F, Bonne G, Romero N, Francois D, Paturneau-Jouas M, et al. Genetic biochemical and pathophysiological characterization of a familial mitochondrial encephalomyopathy (MERRF). J Neurol Sci 1991; 105: 217-24.
45. Servidei S. Mitochondrial encephalomyopathies: gene mutation, Neuromuscul Disord 1998; 8: XIII-IX.
46. Shanske AL, Shanske S, Silvestri G, Tanji K, Wertheim D, Lipper S. MELAS point mutation with unusual clinical presentation. Neuromuscul Disord 1993; 3: 191-3.
47. Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990; 61: 931-7.
48. Silvestri G, Ciafaloni E, Santorelli FM, Shanske S, Servidei S, Graf WD, et al. Clinical features associated with the A→G transition at nucleotide 8344 of mtDNA ('MERRF mutation'). Neurology 1993; 43: 1200-6.
49. Tanno Y, Yoneda M, Tanaka K, Kondo R, Hozumi I, Wakabayashi K, et al. Uniform tissue distribution of tRNA(Lys) mutation in mitochondrial DNA in MERRF patients. Neurology 1993; 43: 1198-200.
50. Tanno Y, Yoneda M, Tanaka K, Tanaka H, Yamazaki M, Nishizawa M, et al. Quantitation of heteroplasmy of mitochondrial tRNA(Leu(UUR)) gene using PCR-SSCP. Muscle Nerve 1995; 18: 1390-7.
51. Traff J, Holme E, Ekbom K, Nilsson BY. Ekbom's syndrome of photomyoclonus, cerebellar ataxia and cervical lipoma is associated with the tRNA(Lys) A8344G mutation in mitochondrial DNA. Acta Neurol Scand 1995; 92: 394-7.
52. Warner TT, Schapira AV. Genetic counselling in mitochondrial diseases. [Review]. Curr Opin Neurol 1997; 10: 408-12.